Cancer research

ECM is a key component of the tumor microenvironment that plays a central role in tumor cell proliferation and metastasis. Tissue-specific ECM substrates, including bone, liver, and lung ECMs, offer a robust, physiologically-relevant platform to study migration, invasion, or metastasis, or test compounds or immunotherapies.

IN SITE™ Metastasis Kit

MTSMS101	IN SITE™ Metastasis Hydrogel Kit
MTSMS201	IN SITE™ Metastasis Surface Coating Kit

Bone ECM cell culture substrates

MTSBN101	TissueSpec® Bone ECM Hydrogel
MTSBN201	NativeCoat™ Bone ECM Surface Coating

Intestine ECM cell culture substrates

MTSIN101	TissueSpec® Intestine ECM Hydrogel
MTSIN201	NativeCoat™ Intestine ECM Surface Coating

Liver ECM cell culture substrates

MTSLV101	TissueSpec® Liver ECM Hydrogel
MTSLV201	NativeCoat™ Liver ECM Surface Coating

Lung ECM cell culture substrates

MTSLG101	TissueSpec® Lung ECM Hydrogel
MTSLG201	NativeCoat™ Lung ECM Surface Coating

Related Resources

White Paper: 3D Lung Tumor Model with Lung Extracellular Matrix to Predict Drug Efficacy

Application Note: IN SITE™ Metastasis Kit to Accelerate Anticancer Drug Development

Publication: Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers (2020)

Poster: TissueSpec® Bone, Liver, and Lung ECM Substrates Enable Disease-Relevant in-vitro Models of Pre-Metastatic Tissue Microenvironments

Webinar: Redefining Cancer Research with IN SITE™ Metastasis Kit